new molecules and indications for glp-1 medicines Ozempic and other GLP-1 drugs

Regulatory Information Disclaimer: Statements in this article regarding FDA actions, the 503B Bulks List, drug shortage status, and the federal regulatory framework for compounded GLP-1 medications reflect FDA published guidance current as of May 2026

Obesity in adolescents is associated with a wide range of metabolic and cardiovascular complications, including type 2 diabetes mellitus, hypertension, dyslipidemia, non-alcoholic fatty liver disease (NAFLD), and early manifestations of cardiovascular disease

Emerging research including new guidance from the InfantRisk Center suggests that the biggest concern during breastfeeding may not be medication transfer into breast milk , but whether the parent is able to consume enough calories and nutrients to support milk production

Additionally, those with severe gastrointestinal disorders, such as gastroparesis, may not tolerate these medications well